Annotation Detail

Information
Associated Genes
TP53
Associated Variants
TP53 DELETERIOUS MUTATION
TP53 DELETERIOUS MUTATION
Associated Disease
chronic lymphocytic leukemia
Source Database
CIViC Evidence
Description
The authors analyzed 328 patients with CLL, of which 28 were identified to have TP53 mutations. Patients with TP53 mutations were found to have significantly shorter progression-free (HR = 3.8; P < 0.001) and overall survival (HR = 7.2; P < 0.001).
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1452
Gene URL
https://civic.genome.wustl.edu/links/genes/45
Variant URL
https://civic.genome.wustl.edu/links/variants/222
Rating
5
Evidence Type
Prognostic
Disease
Chronic Lymphocytic Leukemia
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Poor Outcome
Pubmed
20697090
Drugs